Johnson & Johnson's (NYSE:JNJ) investors will be pleased with …

Oct 22, 2024 · Johnson & Johnson's (NYSE:JNJ) investors will be pleased with their favorable 45% return over the last five years [email protected] (Simply Wall St) Tue, Oct …

CouponFollow Extension

45%
OFF

Johnson & Johnson's (NYSE:JNJ) Investors Will Be Pleased With …

3 weeks from now

Oct 22, 2024 · Johnson & Johnson's (NYSE:JNJ) investors will be pleased with their favorable 45% return over the last five years [email protected] (Simply Wall St) Tue, Oct …

yahoo.com

7%
OFF

Johnson & Johnson (JNJ) Is Attracting Investor Attention: Here Is …

3 weeks from now

Dec 26, 2024 · Johnson & Johnson is expected to post earnings of $2 per share for the current quarter, representing a year-over-year change of -12.7%. Over the last 30 days, the Zacks …

yahoo.com

$1.24
OFF

Johnson & Johnson Announces Quarterly Dividend For First …

3 weeks from now

Jan 2, 2025 · Johnson Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2025 of $1.24 per share on the company’s …

jnj.com

47%
OFF

Johnson & Johnson Announces A Major Acquisition. Can It Turn …

3 weeks from now

1 day ago · Johnson & Johnson (JNJ-0.47%) has a diverse healthcare business, and investors often look to it as a safe dividend stock to invest in for the long term. One area where it has …

fool.com

$193.94
OFF

What Analysts Are Saying About Johnson & Johnson Stock

3 weeks from now

Oct 10, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Johnson & Johnson, presenting an average target of $193.94, a high estimate of $215.00, and a low …

nasdaq.com

3%
OFF

Johnson & Johnson Stock Dives After Strokes Sideline Its Pulsed …

3 weeks from now

Jan 8, 2025 · Johnson & Johnson stock has mostly fallen since early September. Boston Scientific stock jumped 4.3% to close at 95.94, though that could be related to its acquisition of …

investors.com

9%
OFF

Johnson & Johnson Stock Skids After Dow Giant Beat Earnings …

3 weeks from now

Jan 22, 2025 · But Johnson & Johnson stock tumbled 1.9%, closing at 145.27. Shares are now well below their 50-day moving average , according to MarketSurge . J&J Earnings Beat, …

investors.com

7%
OFF

Johnson & Johnson (JNJ) Q4 2024 Earnings Call Highlights: Strong ...

3 weeks from now

Jan 23, 2025 · Q4 2024 Revenue: $22.5 billion, a 6.7% increase. Full Year 2024 Revenue: $88.8 billion, a 5.9% increase. Q4 2024 Net Earnings: $3.4 billion. Q4 2024 Diluted EPS: $1.41, …

yahoo.com

12%
OFF

Will Investors Benefit From Johnson & Johnson's Breakup?

3 weeks from now

Nov 23, 2021 · In one of the biggest surprises of the year, Johnson & Johnson (JNJ 0.12%) has announced that it will break off its consumer health division from its pharmaceutical and …

fool.com

$152.09
OFF

Deane Retirement Strategies Inc. Purchases 9,561 Shares Of …

3 weeks from now

19 hours ago · Why Traders Are Buying the Dip on Johnson & Johnson Stock; Shares of NYSE:JNJ opened at $152.09 on Friday. The company has a market cap of $366.17 billion, a …

marketbeat.com

1%
OFF

Johnson & Johnson (NYSE:JNJ) Trading 1% Higher - Here's Why

3 weeks from now

1 day ago · Johnson & Johnson (NYSE:JNJ - Get Free Report) last issued its quarterly earnings results on Wednesday, January 22nd. The company reported $2.04 earnings per share (EPS) …

marketbeat.com

FAQs about Johnson & Johnson's (NYSE:JNJ) investors will be pleased with … Coupon?

Is Johnson & Johnson (JNJ) a good stock to buy in 2024?

The former segment's growth was aided greatly by sales of oncology drugs, and the latter did brisk business in cardiovascular (thank you, Abiomed) and electrophysiology. Johnson & Johnson (NYSE: JNJ) didn't have an exceptional 2024; in fact, it was one of the worst-performing stocks on the vaunted, 30-company Dow Jones Industrial Average that year. ...

Who will host a Johnson & Johnson investor call?

Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson ’s executive team. ...

Should you buy Johnson & Johnson (JNJ) now?

While speculative, buying JNJ now at a good valuation with a high dividend yield presents a favorable risk-reward balance. Johnson & Johnson (NYSE: JNJ) (NEOE: JNJ:CA) started this year at the same price as it started 2020. ...

Should you invest in Johnson & Johnson (JNJ) stock?

Johnson & Johnson ( NYSE:JNJ) stock’s investment case is highly correlated with its underlying dividend prospects. As a healthcare giant with iconic brands like Band-Aid and Listerine, along with a diverse pharmaceutical and medical device portfolio, Johnson & Johnson has earned the trust of income-focused investors. ...

Should you buy Johnson & Johnson (JNJ) in 2025?

Johnson & Johnson's stagnant price and bond-like behavior make it an income investment, but a market shift could boost its appeal in 2025. Value stocks, including JNJ, may gain favor as growth stocks' earnings slow and proposed policies boost earnings in other sectors. ...

Is Johnson & Johnson (JNJ) a good dividend stock?

The company will expand J&J's pipeline and could pave the way for more growth in the future. Johnson & Johnson (JNJ -0.47%) has a diverse healthcare business, and investors often look to it as a safe dividend stock to invest in for the long term. One area where it has been lacking, however, is growth. ...